PureWow editors select every item that appears on this page, and some items may be gifted to us. Additionally, PureWow may ...

The investment firm BayPine has agreed to acquire CenExel Clinical Research for about $1.5 billion, according to people ...

Shopping online is not only convenient, it can also help credit card holders earn certain rewards that they might not receive ...

Discover the truth behind PrimeBiome reviews and find out how this gut-skin supplement transformed my skin after years of ...

To that end, let's consider five excellent growth-oriented companies to invest in on the dip: Novo Nordisk ( NVO -1.69%), Eli ...

[SINGAPORE] Clinical research and testing provider Novotech on Monday (Mar 31) announced that Temasek and GIC will acquire a “significant stake in the company”, and that existing investor TPG will be ...

Consequently, investors might wonder whether it’s smart to buy the iShares Bitcoin Trust ETF. There are risks involved, no doubt, but Bitcoin bulls can still find compelling reasons to hold ...

Investing.com -- Bank of America reaffirmed its Buy rating on Nvidia (NASDAQ:NVDA) shares, stressing that the chipmaker’s valuation is “still compelling” despite growing geopolitical risks.

This practical, one-day course provides a detailed discussion of the legal, regulatory, drafting and practice issues that arise when drafting and negotiating clinical trial agreements ... to your ...

This is still as dependable a business as investors could hope for. Most people buy PepsiCo stock for the dividend. The company is a Dividend King, and that's unlikely to change anytime soon.

In a conversation at the Exchange conference in Las Vegas, which has brought together about 2,000 investment advisors and asset managers, Dominic Rizzo, global technology portfolio manager at T.